7.600
+0,00%
2026-10-19
Fundamental Analysis
59 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -54.3% | +99.2% | 1 / 3 | +38.3% | +6.34 pp | -1.26 pp | +16.3% | 0.32 | 4.81 | 69,2 | +38,3% | 0,8 | −32,6% | 4.81 | 1.91 | +151,8% |
| Pts | 0 | 12 | 4 | 12 | 12 | 4 | 4 | 12 | 4 | |||||||
Valuation annotation:Price: 7.600 (close price on 2026-10-19)EPS (TTM): 1.580
Financial charts
1.Revenue & growth
VND bn69,2Q2/26
1.Revenue & growth
VND bn69,2Q2/26
2.Profit & growth
VND bn0,83Q2/26
3.Profit mix (Penman)
VND bn31,2Q2/26
4.Margins & cost structure
%35.5%Q2/26
5.Returns & cash cycle
% · days11.4%Q2/26
6.Earnings quality & cash
VND bn4,20Q2/26
7.Asset structure
VND bn317Q2/26
8.Funding & debt health
VND bn · times317Q2/26
9.Revenue backlog
VND bn1,45Q2/26
10.Valuation
times · %5,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %44Q2/26
Adjusted EPS growth, latest quarter
-52.0%
Average adjusted EPS growth, 3 quarters
100.0%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
40.4%
Source: vnstockData through Q2/26